Monophosphoryl lipid A, a derivative of bacterial lipopolysaccharide, fails to induce B1-receptor-dependent responses to (des-Arg9)-bradykinin in the rabbit in vivo

Immunopharmacology

Volumn 41, Issue 2, 1999, Pages 165-168

  Mazenot, Catherine ^a   Ribuot, Christophe ^a   Demenge, Pierre ^a   Godin Ribuot, Diane ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Arterial pressure; B1 receptors; Lipopolysaccharide; Monophosphoryl lipid A; Rabbit

Indexed keywords

ARGIPRESSIN[DEGLYCINAMIDE]; BRADYKININ; BRADYKININ RECEPTOR; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; PHOSPHORYL LIPID A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART PROTECTION; HYPOTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADJUVANTS, IMMUNOLOGIC; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BRADYKININ; LIPID A; LIPOPOLYSACCHARIDES; MALE; RABBITS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0032984472     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00065-4     Document Type: Article

References (15)

1. Baxter G.F., Goodwin R.W., Wright M.J., Kerac M., Heads R.J., Yellon D.M. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischemic properties in rabbit heart. Br. J. Pharmacol. 117:1996;1685-1692.
2. Bouchard J.-F., Chouinard J., Lamontagne D. Role of kinins in the endothelial protective effects of ischaemic preconditioning. Br. J. Pharmacol. 123:1998;413-420.
3. 9]-bradykinin in vitro and in vivo. Br. J. Pharmacol. 92:1987;257-264.
4. 1 receptors. Br. J. Pharmacol. 108:1993;318-322.
5. 9]-bradykinin. Br. J. Pharmacol. 93:1988;969-977.
6. Elliott G.T. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischaemia-reperfusion injury. J. Mol. Cell. Cardiol. 30:1998;3-17.
7. Henricson B.E., Manthey C.L., Perera P.Y., Hamilton T.A., Vogel S.N. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61:1993;2325-2333.
8. 1-receptor synthesis induction by heat stress in the rat. Br. J. Pharmacol. 121:1997;1045-1046.
9. Parratt J.R., Vegh A., Papp J.G. Bradykinin as an endogenous myocardial protective substance with particular reference to ischaemic preconditioning - a brief review of the evidence. Can. J. Physiol. Pharmacol. 73:1995;837-842.
10. Regoli D., Barnabe J., Park W.K. Receptors for bradykinin in the rabbit aortae. Can. J. Physiol. Pharmacol. 55:1977;855.
11. 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur. J. Pharmacol. 71:1981;105-115.
12. Ribi E. Beneficial modification of the endotoxin molecule. J. Biol. Response Mod. 3:1984;1-9.
13. Vegh A., Papp J.G., Elliott G.T., Parratt J.R. Pretreatment with monophosphoryl lipid A (MPL®-C) reduces ischaemia-induced arrythmias in dogs. J. Mol. Cell. Cardiol. 28:1996;A56.
14. Yao Z., Elliott G.T., Gross G.J. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc. Res. 27:1993;832-838.
15. Zhao L., Kirsch C.C., Hagen S.R., Elliott G.T. Preservation of global cardiac function in the rabbit following protracted ischaemia/reperfusion using mono-phosphoryl lipid A (MLA). J. Mol. Cell. Cardiol. 28:1996;197-208.